FY2026 EPS Forecast for Core Scientific Increased by Analyst

Key Points

• Analysts at HC Wainwright increased their FY2026 EPS estimate for Core Scientific from $0.82 to $0.95, while maintaining a "Neutral" rating on the stock.
• Core Scientific reported a quarterly EPS of ($0.04), beating the consensus estimate of ($0.07), although revenue fell by 44.3% compared to the same quarter last year.
• Insider activity includes a significant buy by Director Yadin Rozov, who acquired 110,000 shares at an average price of $10.87 per share, increasing his stake by 30.08%.

Core Scientific, Inc. (NASDAQ:CORZ - Free Report) - Equities researchers at HC Wainwright lifted their FY2026 EPS estimates for Core Scientific in a note issued to investors on Monday, August 11th. HC Wainwright analyst K. Dede now expects that the company will post earnings per share of $0.95 for the year, up from their previous forecast of $0.82. HC Wainwright has a "Neutral" rating on the stock. The consensus estimate for Core Scientific's current full-year earnings is $0.52 per share.

Core Scientific (NASDAQ:CORZ - Get Free Report) last posted its quarterly earnings data on Friday, August 8th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.03. The company had revenue of $78.63 million for the quarter, compared to analysts' expectations of $82.09 million. The firm's revenue for the quarter was down 44.3% compared to the same quarter last year.

Other equities analysts also recently issued reports about the stock. Craig Hallum downgraded shares of Core Scientific from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 7th. Arete Research raised shares of Core Scientific to a "strong-buy" rating in a research note on Tuesday, July 22nd. JMP Securities reissued a "market perform" rating and issued a $15.00 price target on shares of Core Scientific in a research note on Monday, July 14th. B. Riley downgraded shares of Core Scientific from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, July 9th. Finally, Roth Capital reissued a "neutral" rating and issued a $20.00 price target on shares of Core Scientific in a research note on Tuesday, July 8th. One analyst has rated the stock with a sell rating, eleven have given a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Core Scientific currently has an average rating of "Hold" and an average target price of $18.32.

Core Scientific Stock Up 0.8%

CORZ opened at $14.53 on Tuesday. The firm's fifty day simple moving average is $13.63 and its two-hundred day simple moving average is $10.93. The company has a market cap of $4.33 billion, a price-to-earnings ratio of -25.95 and a beta of 6.60. Core Scientific has a 52-week low of $6.20 and a 52-week high of $18.63.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. HHM Wealth Advisors LLC lifted its stake in Core Scientific by 96.5% in the second quarter. HHM Wealth Advisors LLC now owns 1,926 shares of the company's stock worth $33,000 after acquiring an additional 946 shares during the last quarter. State of Wyoming purchased a new position in Core Scientific in the first quarter worth approximately $34,000. Emerald Mutual Fund Advisers Trust purchased a new position in Core Scientific in the first quarter worth approximately $38,000. Mirae Asset Global Investments Co. Ltd. purchased a new position in Core Scientific in the first quarter worth approximately $50,000. Finally, Bernard Wealth Management Corp. purchased a new position in Core Scientific in the second quarter worth approximately $51,000.

Insider Buying and Selling

In other Core Scientific news, Director Yadin Rozov acquired 110,000 shares of the company's stock in a transaction that occurred on Wednesday, May 28th. The stock was purchased at an average price of $10.87 per share, for a total transaction of $1,195,700.00. Following the completion of the acquisition, the director owned 475,687 shares of the company's stock, valued at approximately $5,170,717.69. This trade represents a 30.08% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Todd M. Duchene sold 60,000 shares of Core Scientific stock in a transaction that occurred on Tuesday, June 3rd. The shares were sold at an average price of $11.33, for a total transaction of $679,800.00. Following the completion of the transaction, the insider owned 2,100,102 shares of the company's stock, valued at $23,794,155.66. This trade represents a 2.78% decrease in their position. The disclosure for this sale can be found here. Insiders sold 117,759 shares of company stock valued at $1,391,434 in the last 90 days. Company insiders own 1.40% of the company's stock.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.